Based in Germany, Biolam is a startup founded in 2017. Brouky records 1 investor associated with the company.
Biolam develops and produces innovative solutions for life sciences and medical technology, focusing on advanced materials and surface modifications. Their technology aims to enhance the performance and biocompatibility of medical devices and diagnostic tools.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.